# Kyntra Bio, Inc. (KYNB)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/KYNB/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 3.74M | $ -15.20M | $ -13.89M | $ 0 | $ -9.29M |
| 2025 | $ 6.60M | $ 134.43M | $ -4.93M | $ 0 | $ 4.48M |
| 2024 | $ -53.14M | $ -50.01M | $ -145.33M | $ 90.17M | $ -225.60M |
| 2023 | $ 159.76M | $ -307.33M | $ -343.34M | $ 170.46M | $ -204.17M |
| 2022 | $ 157.22M | $ -328.04M | $ -206.30M | $ 89.89M | $ -21.45M |
| 2021 | $ 279.70M | $ -344.74M | $ -133.63M | $ 99.72M | $ 209.15M |
| 2020 | $ 224.62M | $ -241.14M | $ 98.87M | $ 39.76M | $ 422.18M |
| 2019 | $ 331.18M | $ -99.35M | $ -109.03M | $ 51.89M | $ 516.14M |
| 2018 | $ 281.25M | $ -114.13M | $ -111.15M | $ 97.16M | $ 509.20M |
| 2017 | $ 169.29M | $ -170.01M | $ -101.05M | $ 97.76M | $ 563.18M |
| 2016 | $ 247.07M | $ -84.86M | $ 8.06M | $ 97.35M | $ 155.84M |
| 2015 | $ 253.89M | $ -120.44M | $ -28.85M | $ 97.04M | $ 177.55M |
| 2014 | $ 194.43M | $ -84.08M | $ 20.20M | $ 97.22M | $ 221.41M |
| 2013 | $ 145.31M | $ -21.25M | $ 27.18M | $ 96.81M | $ 79.73M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | -12.80 |
| Current Ratio | 3.61 |

## Other views

- [Metrics](https://sponda.capital/en/KYNB.md)
- [Charts](https://sponda.capital/en/KYNB/charts.md)
- [Compare](https://sponda.capital/en/KYNB/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.